The severity of the first 207 infections with the SARS-CoV-2 Omicron BA.2 variant, in Marseille, France, December 2021-February 2022
- PMID: 35365865
- PMCID: PMC9088598
- DOI: 10.1002/jmv.27760
The severity of the first 207 infections with the SARS-CoV-2 Omicron BA.2 variant, in Marseille, France, December 2021-February 2022
Conflict of interest statement
Didier Raoult has a conflict of interest, having been a consultant for Hitachi High‐Technologies Corporation, Tokyo, Japan, from 2018 to 2020. He is a scientific board member of Eurofins company and a founder of a microbial culture company (Culture Top). Other authors declare no conflicts of interest.
References
-
- Santé Publique France . COVID‐19. Point epidémiologique. N°103. Accessed February 17, 2022. https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-et-...
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous